Cargando…
Nonviral delivery systems for antisense oligonucleotide therapeutics
Antisense oligonucleotides (ASOs) are an important tool for the treatment of many genetic disorders. However, similar to other gene drugs, vectors are often required to protect them from degradation and clearance, and to accomplish their transport in vivo. Compared with viral vectors, artificial non...
Autores principales: | Huang, Si, Hao, Xin-Yan, Li, Yong-Jiang, Wu, Jun‑Yong, Xiang, Da-Xiong, Luo, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523189/ https://www.ncbi.nlm.nih.gov/pubmed/36180936 http://dx.doi.org/10.1186/s40824-022-00292-4 |
Ejemplares similares
-
Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
por: Markov, Oleg V., et al.
Publicado: (2020) -
Nonviral gene delivery system
por: Yang, Ningning
Publicado: (2012) -
Viral and nonviral delivery systems for gene delivery
por: Nayerossadat, Nouri, et al.
Publicado: (2012) -
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021) -
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
por: Novak, James S., et al.
Publicado: (2017)